Silva Guisasola Jacobo, Alvarez-Cabo Rubén, Hernández-Vaquero Daniel, Méndez Rocío Díaz
Department of Cardiac Surgery, Hospital Universitario Central de Asturias, Oviedo, Spain.
J Thorac Dis. 2017 May;9(Suppl 6):S448-S453. doi: 10.21037/jtd.2017.05.01.
Ascending aorta reinterventions present a challenge for surgeons as the technical difficulties of the procedure and the complex strategic approach can complicate successful treatment. These patients should be treated by surgical teams with ample experience in aortic diseases as they can be at high risk of mortality. The number of interventions on the ascending aorta and aortic arch and the use of biological conducts (lung autograft, homograft, etc.) have increased in recent years; therefore, the number of reinterventions can also be expected to increase, representing 10% of aortic surgical procedures. This article reviews the current status of ascending aorta reinterventions, analyzing the principal aspects of indication and surgical strategy, as well as the results published in the largest studies.
升主动脉再次干预对外科医生来说是一项挑战，因为该手术的技术难度和复杂的策略方法可能会使成功治疗变得复杂。这些患者应由在主动脉疾病方面有丰富经验的外科团队进行治疗，因为他们可能面临较高的死亡风险。近年来，升主动脉和主动脉弓的干预次数以及生物导管（肺自体移植、同种异体移植等）的使用有所增加；因此，再次干预的次数预计也会增加，占主动脉外科手术的10%。本文回顾了升主动脉再次干预的现状，分析了适应证和手术策略的主要方面，以及在最大规模研究中发表的结果。
